Walden, United Kingdom

Helen Rachel Bignell

This inventor holds 11 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Illumina Cambridge Limited, Cambridge Epigenetix Limited. Active years: 2011-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helen Rachel Bignell. Retrieved from https://idiyas.com/inventor/helen-rachel-bignell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.3

ph-index = 5

Forward Citations = 394(Granted Patents)


Location History:

  • Essex, GB (2012)
  • Saffron Walden, GB (2014 - 2015)
  • Walden, GB (2011 - 2016)
  • Nr Saffron Walden, GB (2016)
  • Cambridge, GB (2018 - 2023)

Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Helen Rachel Bignell: Pioneering Innovator from Walden, Great Britain

Introduction: Helen Rachel Bignell's unwavering passion for innovation and commitment to excellence have established her as a trailblazing inventor in Walden, Great Britain, and beyond. Her groundbreaking work serves as an inspiration for future generations of inventors, encouraging them to explore the realms of the possible.

Latest Patents: Helen Rachel Bignell holds a remarkable total of 11 patents, including her latest inventions:

1. Methods for indexing samples and sequencing multiple polynucleotide templates: These methods revolutionize the sequencing of polynucleotide templates by attaching specific tags to nucleic acid samples, enabling the identification of both the source and sequence of each polynucleotide. This innovation is particularly valuable in analyzing complex genomes like human genomes and multiplexing less complex genomes such as bacteria, viruses, and mitochondria.

2. Methods for analyzing nucleic acids: Helen's methods, systems, and compositions offer advanced techniques for determining bases in polynucleotides, allowing for 4-base, 5-base, or 6-base sequencing of molecules, especially in low-frequency mutation scenarios or liquid biopsy samples.

Career Highlights: Helen Rachel Bignell has made significant contributions to pioneering companies in the industry, including Illumina Cambridge Limited and Cambridge Epigenetix Limited. Her innovative spirit and exceptional expertise have led to groundbreaking advancements in genomic research and sequencing technologies.

Collaborations: Throughout her career, Helen has collaborated with esteemed professionals in the field, including Niall Anthony Gormley and Louise Fraser. These collaborations have enriched her work and contributed to the success of her inventions.

Conclusion: Helen Rachel Bignell's remarkable journey as an inventor showcases her dedication to pushing the boundaries of innovation in genomics and sequencing technologies. Her legacy as a pioneering inventor from Walden, Great Britain, resonates across the industry, inspiring new generations of inventors to explore the realms of possibility and shape the future of scientific discovery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…